Expert Reviews in Molecular Medicine最新文献

筛选
英文 中文
Modulation of Female Reproductive Functions through Nerve Growth Factor: A Systematic Review. 神经生长因子对女性生殖功能调节的系统综述。
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-05-08 DOI: 10.1017/erm.2026.10050
Yanru Lou, Shuo Huang, Xi Zhang, Wei Guo, Lina Yi, Leihan Wang, Shuangyi Gong, Jie Yan, Rui Yang
{"title":"Modulation of Female Reproductive Functions through Nerve Growth Factor: A Systematic Review.","authors":"Yanru Lou, Shuo Huang, Xi Zhang, Wei Guo, Lina Yi, Leihan Wang, Shuangyi Gong, Jie Yan, Rui Yang","doi":"10.1017/erm.2026.10050","DOIUrl":"https://doi.org/10.1017/erm.2026.10050","url":null,"abstract":"","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"1-19"},"PeriodicalIF":5.5,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of acupuncture in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and Meta-analysis. 针灸对体外受精多囊卵巢综合征妇女的影响:一项系统综述和meta分析。
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-05-04 DOI: 10.1017/erm.2026.10048
Lina Yi, Haolin Zhang, Tian Tian, Yaodong Zhang, Yanru Lou, Jialin Li, Chenhong Liu, Caihong Ma, Ping Liu, Rong Li, Jie Qiao, Shuo Huang, Rui Yang
{"title":"The effect of acupuncture in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and Meta-analysis.","authors":"Lina Yi, Haolin Zhang, Tian Tian, Yaodong Zhang, Yanru Lou, Jialin Li, Chenhong Liu, Caihong Ma, Ping Liu, Rong Li, Jie Qiao, Shuo Huang, Rui Yang","doi":"10.1017/erm.2026.10048","DOIUrl":"https://doi.org/10.1017/erm.2026.10048","url":null,"abstract":"","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"1-25"},"PeriodicalIF":5.5,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147823088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity-Related Cognitive Impairment: An update overview of mechanisms and treatments. 肥胖相关认知障碍:机制和治疗的最新综述
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-05-04 DOI: 10.1017/erm.2026.10049
Chuanyu Zhong, Kai Chen, Shu Lin, Yinqiong Huang
{"title":"Obesity-Related Cognitive Impairment: An update overview of mechanisms and treatments.","authors":"Chuanyu Zhong, Kai Chen, Shu Lin, Yinqiong Huang","doi":"10.1017/erm.2026.10049","DOIUrl":"https://doi.org/10.1017/erm.2026.10049","url":null,"abstract":"","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"1-37"},"PeriodicalIF":5.5,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147823043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When GPVI Goes Rogue: Pathogenesis and Therapeutic Horizons in ITP. 当GPVI失控:ITP的发病机制和治疗前景。
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-04-13 DOI: 10.1017/erm.2026.10047
Jalal Naghinezhad, Ahmad Mohajerian, Shana Ahadi, Nastaran Khodakarim, Michael R Hamblin, Hadi Rezaeeyan
{"title":"When GPVI Goes Rogue: Pathogenesis and Therapeutic Horizons in ITP.","authors":"Jalal Naghinezhad, Ahmad Mohajerian, Shana Ahadi, Nastaran Khodakarim, Michael R Hamblin, Hadi Rezaeeyan","doi":"10.1017/erm.2026.10047","DOIUrl":"https://doi.org/10.1017/erm.2026.10047","url":null,"abstract":"","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"1-41"},"PeriodicalIF":5.5,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147678576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Tumor-Platelet-Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation, and Therapeutic Vulnerabilities. 肿瘤-血小板-免疫界面:驱动转移、转移前生态位形成和治疗脆弱性。
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-04-07 DOI: 10.1017/erm.2026.10043
Jalal Naghinezhad, Ehsan Kamali Yazdi, Ahmad Mohajerian, Negin Yousefi Chermehini, Pedram Ghanavati, Hamid Motamedi, Hadi Rezaeeyan
{"title":"The Tumor-Platelet-Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation, and Therapeutic Vulnerabilities.","authors":"Jalal Naghinezhad, Ehsan Kamali Yazdi, Ahmad Mohajerian, Negin Yousefi Chermehini, Pedram Ghanavati, Hamid Motamedi, Hadi Rezaeeyan","doi":"10.1017/erm.2026.10043","DOIUrl":"https://doi.org/10.1017/erm.2026.10043","url":null,"abstract":"","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"1-34"},"PeriodicalIF":5.5,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147628671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Antibiotics: Alternative Strategies Targeting Helicobacter pylori Resistance. 超越抗生素:针对幽门螺杆菌耐药性的替代策略。
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-04-07 DOI: 10.1017/erm.2026.10040
Amin Fath Tabar, Azar Nejati, Seyedeh Nasim Mirbahari, Mohammad Rahmanian, Ehsan Nazemalhosseini Mojarad, Zahra Sadeghloo, Hamideh Raeisi
{"title":"Beyond Antibiotics: Alternative Strategies Targeting <i>Helicobacter pylori</i> Resistance.","authors":"Amin Fath Tabar, Azar Nejati, Seyedeh Nasim Mirbahari, Mohammad Rahmanian, Ehsan Nazemalhosseini Mojarad, Zahra Sadeghloo, Hamideh Raeisi","doi":"10.1017/erm.2026.10040","DOIUrl":"10.1017/erm.2026.10040","url":null,"abstract":"<p><p>The escalating global prevalence of antibiotic-resistant <i>Helicobacter pylori</i> strains has undermined conventional eradication therapies, heightening the burden of associated conditions such as gastritis, peptic ulcers and gastric malignancies. Emerging non-antibiotic alternatives, including natural and synthetic compounds, probiotics and vaccine candidates, offer potential solutions to combat these infections effectively. Natural and synthetic compounds provide promising anti-<i>H. pylori</i> effects, primarily through bacterial membrane disruption, urease inhibition, virulence gene suppression and biofilm prevention. in vitro and in vivo studies support the robust activity of natural agents, while synthetic counterparts demonstrate potent bactericidal and anti-adherence capabilities, though rigorous clinical validation is still required. Probiotic strains enhance eradication rates when combined with antibiotics, reduce treatment-related adverse effects, modulate gut microbiota and attenuate gastric inflammation and carcinogenesis. Vaccine development encompasses whole-cell, subunit and DNA platforms targeting key virulence factors, showing immunogenicity and protective efficacy in preclinical models, yet is limited by variable clinical translation and insufficient large-scale trials. Despite promising advancements, challenges persist, including inconsistent efficacy and a need for more rigorous human studies. Future efforts should emphasize combinatorial therapies, refined delivery systems, and thorough safety evaluations to integrate these strategies into clinical practice, fostering sustainable management of <i>H. pylori</i> in a post-antibiotic era.</p>","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"e18"},"PeriodicalIF":5.5,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147628649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From lactate to lactylation: novel pathological mechanisms and potential therapeutic targets for high-altitude cerebral oedema. 从乳酸到乳酸化:高原脑水肿的新病理机制和潜在治疗靶点。
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-04-06 DOI: 10.1017/erm.2026.10046
Chaoyi Duan, Siyu Li, Likun Yao, Xinjie Zhang, Yansheng Ding, BiWen Peng
{"title":"From lactate to lactylation: novel pathological mechanisms and potential therapeutic targets for high-altitude cerebral oedema.","authors":"Chaoyi Duan, Siyu Li, Likun Yao, Xinjie Zhang, Yansheng Ding, BiWen Peng","doi":"10.1017/erm.2026.10046","DOIUrl":"10.1017/erm.2026.10046","url":null,"abstract":"<p><strong>Background: </strong>High altitude cerebral edema (HACE), a fatal terminal stage of acute mountain sickness (AMS), is triggered by rapid exposure to hypoxia at high altitudes. The pathophysiology of HACE is complex, involving multiple key processes including energy metabolism disorders, oxidative stress, blood-brain barrier (BBB) injury, and neuroinflammation, all of which interact to drive disease progression. Lactylation, a novel epigenetic regulatory mechanism discovered in 2019, provides a fresh perspective for HACE research.</p><p><strong>Methods: </strong>This study integrates the latest research findings on the pathophysiology of HACE, lactate metabolism, and the role of lactylation in hypoxia-related diseases (such as cancer and ischemic-hypoxic diseases). It focuses on analyzing the potential molecular mechanisms of lactylation in HACE, including its regulation of the HIF-1α/NF-κB axis, inflammation, and metabolism, and discusses existing lactylation regulation strategies.</p><p><strong>Results: </strong>In HACE, hypoxia-driven glycolysis elevates lactate, promoting protein lactylation (e.g., NuRD complex in microglia, which is correlated with proinflammatory cytokines). Lactylation may regulate HIF-1α/NF-κB axis, inflammation, and metabolism in HACE pathogenesis. Currently, methods such as the inhibition of lactate dehydrogenase (LDH) /monocarboxylate transporters and the use of histone deacetylase inhibitors have been proven effective in regulating lactylation.</p><p><strong>Conclusion: </strong>Lactylation is a key link connecting metabolic disorders and neuroinflammation in HACE. However, the dual role of lactate in neuroprotection and neuroinjury under hypoxic conditions still requires further exploration. Future research should focus on deciphering the molecular networks related to HACE and developing precise intervention strategies to provide new directions for HACE treatment.</p>","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"e16"},"PeriodicalIF":5.5,"publicationDate":"2026-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147624474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxeiptosis - potential in cancer treatment? 氧上下垂-癌症治疗的潜力?
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-03-27 DOI: 10.1017/erm.2026.10045
Mateusz Kciuk, Katarzyna Wanke, Żaneta Kałuzińska-Kołat, Renata Kontek
{"title":"Oxeiptosis - potential in cancer treatment?","authors":"Mateusz Kciuk, Katarzyna Wanke, Żaneta Kałuzińska-Kołat, Renata Kontek","doi":"10.1017/erm.2026.10045","DOIUrl":"10.1017/erm.2026.10045","url":null,"abstract":"<p><p>Oxeiptosis is a reactive oxygen species (ROS)-dependent form of programmed cell death that plays a key role in cellular homeostasis and holds promise as a cancer therapy. This review explores its molecular mechanisms, emphasizing the KEAP1-PGAM5-AIFM1 signalling pathway and its reliance on ROS accumulation. Compared to other cell death pathways, oxeiptosis offers a distinct approach, especially for targeting cancer cells resistant to conventional therapies. The review evaluates emerging inducers, both synthetic and natural, that selectively trigger oxeiptosis in cancer cells. It also examines the potential synergy between oxeiptosis and ROS-generating chemotherapies, particularly in the oxidative tumour microenvironment. However, challenges remain, including identifying tumour-specific inducers, overcoming cancer cell resistance to oxidative stress and reducing off-target effects. The review concludes by highlighting the need for targeted delivery strategies and rigorous preclinical studies to translate oxeiptosis into effective cancer treatments. Overall, it underscores oxeiptosis as a promising avenue to address drug resistance and improve therapeutic outcomes in oncology.</p>","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"e15"},"PeriodicalIF":5.5,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147522672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypoxia and HIF signalling in tumour microenvironment: linking immune evasion, metabolic rewiring and epigenetic regulation. 肿瘤微环境中的缺氧和HIF信号:连接免疫逃避、代谢重新布线和表观遗传调控。
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-03-27 DOI: 10.1017/erm.2026.10044
Shadiya Fawzul Ameer, Elham Abdul Latif M Sharif, Wisam Nabeel Ibrahim
{"title":"Hypoxia and HIF signalling in tumour microenvironment: linking immune evasion, metabolic rewiring and epigenetic regulation.","authors":"Shadiya Fawzul Ameer, Elham Abdul Latif M Sharif, Wisam Nabeel Ibrahim","doi":"10.1017/erm.2026.10044","DOIUrl":"10.1017/erm.2026.10044","url":null,"abstract":"<p><strong>Background: </strong>Hypoxia is a defining feature of the tumour microenvironment (TME) that drives aggressive tumour behaviour through coordinated adaptive responses. Hypoxia-inducible factors (HIFs), particularly HIF-1α, play a central role in orchestrating metabolic, immune and epigenetic reprogramming within tumours.</p><p><strong>Objective: </strong>This review aims to elucidate the integrated roles of hypoxia in regulating angiogenesis, immune suppression, metabolic adaptation and epigenetic modifications, and to highlight their collective impact on tumour progression and therapeutic resistance.</p><p><strong>Methods: </strong>A comprehensive review of current literature was conducted to examine the molecular and cellular mechanisms mediated by hypoxia and HIF signalling within the TME, with a focus on their interplay across angiogenic, immune, metabolic and epigenetic pathways.</p><p><strong>Results: </strong>HIF-1α promotes the expression of pro-angiogenic factors, including VEGF, ANGPT2 and CXCL12, leading to abnormal vascularisation and recruitment of immunosuppressive cells such as regulatory T cells and myeloid-derived suppressor cells. This disorganised vasculature exacerbates hypoxia, reinforcing a cycle of immune evasion and metabolic stress. Hypoxia also upregulates immune checkpoint molecules (e.g., PD-L1, PD-1), contributing to T-cell exhaustion and impaired dendritic cell function. Concurrently, metabolic reprogramming-characterised by increased glycolysis, lactate accumulation and extracellular acidification-suppresses cytotoxic T cell and NK cell activity. Epigenetic regulators, including histone demethylases and DNA methyltransferases, sustain these adaptations through persistent transcriptional changes, referred to as hypoxic memory.</p><p><strong>Conclusion: </strong>Hypoxia acts as a central organising force within the TME, coordinating angiogenic, immune, metabolic and epigenetic processes to promote tumour progression. Targeting HIF-driven pathways represents a promising therapeutic strategy to overcome immune resistance, enhance drug delivery and improve the efficacy of combination treatments, including immunotherapy and metabolic interventions. This review underscores the importance of integrated approaches to disrupt hypoxia-mediated tumour adaptation.</p>","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"e14"},"PeriodicalIF":5.5,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148424/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147522654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting JAK/STAT Signaling with Cold Atmospheric Plasma: A Potential Therapy for Systemic Lupus Erythematosus. 低温大气血浆靶向JAK/STAT信号:系统性红斑狼疮的潜在治疗方法
IF 5.5 2区 医学
Expert Reviews in Molecular Medicine Pub Date : 2026-03-24 DOI: 10.1017/erm.2026.10042
Xiaofeng Dai, Yuting Fan
{"title":"Targeting JAK/STAT Signaling with Cold Atmospheric Plasma: A Potential Therapy for Systemic Lupus Erythematosus.","authors":"Xiaofeng Dai, Yuting Fan","doi":"10.1017/erm.2026.10042","DOIUrl":"https://doi.org/10.1017/erm.2026.10042","url":null,"abstract":"","PeriodicalId":50462,"journal":{"name":"Expert Reviews in Molecular Medicine","volume":" ","pages":"1-32"},"PeriodicalIF":5.5,"publicationDate":"2026-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147505463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书